糖槭叶枯病发病规律及防治

糖槭叶枯病 Phyllosticta negundinis病菌孢子放散开始期和高峰期与每年的温、湿度变化有关。病害发生严重程度与降雨量关系密切 ,降雨早且量大时病害严重。病菌以分生孢子器和分生孢子在病叶上越冬 ,通过气流传播成为翌年初侵染源。喷洒 70 %甲基托布津可湿性粉剂 10 0 0倍液和 75%百菌清可湿性粉剂 80 0倍液均能收到较好的效果     

Lactate Kinetics in veterinary Critical Care: A Review

Elevation in blood lactate concentration, with or without accompanying metabolic acidosis, is a hallmark finding in patients with circulatory compromise, and is also consistently noted in other conditions affecting critically ill or injured individuals. Little is reported in a veterinary literature regarding lactate measurement in the emergency and critical care setting, despite impressive reports of the clinical usefulness of lactate measurement in people. The purpose of this article is to review lactate kinetics and the clinical utility of lactate measurement. Limitations to lactate evaluation will also be discussed.     

Pathotypes of Synchytrium endobioticum in Germany

Results are given of a survey on the occurrence of pathotypes (races) of Synchytrium endobioticum (potato wart) in both parts of re-unified Germany. An assortment of six differential cultivars appears to be sufficient to distinguish between the seven presently important German wart pathotypes. A total of ten pathotypes was recorded. Two West and two East German pathotypes seem to be identical, based on the results obtained with presently available cultivars. In contrast to pathotype 1 (common race) which prior to 1945 was distributed over the whole German territory, the 'new' pathotypes seem to prefer the central and south German mountain areas.     

O,O-二烷基-N-莰-2-基(硫)磷酰胺酯的合成

合成了14个含有 N-莰-2-基的磷酰胺和硫代磷酰胺类化合物,用红外、核磁及元素分析确定其结构,并探讨了~(31)Pδ值的规律性变化。初步生物试验表明,磷酰胺类化合物对水稻发芽具有明显的抑制作用,其中化合物Ⅱ1的活性大于对照药剂抗倒胺但低于多效唑。     

Heterosis and recombination effects in Hampshire and Landrace swine: II. Performance and carcass traits.

Twelve different mating types among the Hampshire and Landrace breeds were used to determine direct, maternal, heterosis, and recombination effects for performance and carcass traits. Mating types used were two purebred, two F1, two F2, two F3, and four backcross. Carcass data were collected on 238 barrows and 262 gilts over four replications. Traits measured were length (LENG), 10th rib off midline backfat (BF10), longissimus muscle area (LMA), and dressing percentage (DRS%). Average backfat (AVBF) was calculated as the mean of three midline fat depths measured opposite the first rib, last rib, and last lumbar vertebra. The model used to evaluate the carcass traits included main effects of mating type, farrowing season, and sex and included slaughter weight as a covariate. The performance traits of ADG, feed efficiency (FE), daily feed consumption (DFC), lean gain per day (LNGN), and lean efficiency (LNEF) were measured on a pen basis. Comparisons of reciprocal F1 crosses showed that carcasses from pigs sired by Hampshire boars were leaner and had more LMA than those sired by Landrace boars. Heterosis percentages were significant for AVBF (7.2%; P less than .01), BF10 (8.8%; P less than .01), DRS% (1.5%; P less than .01), ADG (11.5%; P less than .01), DFC (10.2%; P less than .01), LNGN (10.6%; P less than .01), and LNEF (6.0%; P less than .05). Epistatic recombination losses in the offspring were significant for LENG (3.6 cm; P less than .05) and approached significance for BF10 (6.1 mm; P less than .10).     

Pharmacokinetic evaluation of ceftiofur in serum, tissue chamber fluid and bronchial secretions from healthy beef-bred calves.

Ceftiofur is a new broad spectrum cephalosporin marketed for the treatment of acute bovine respiratory disease. In this investigation ceftiofur was administered by intramuscular injection, at 24 h intervals, to healthy beef-bred calves for four days at dosages of 2.2 and 4.4 mg/kg of body weight, with 4 wk intervals between dosing regimens. Serum, tissue chamber fluid (TCF), and bronchial secretion (BS) concentrations of ceftiofur were measured by microbiological assay after the first and fourth dose of each dosing regimen. Peak serum concentrations (Cmax) of 8.8 micrograms/mL and 17.3 micrograms/mL were obtained approximately 2 h (Tmax), the time of mean peak concentration) after single injections of 2.2 mg/kg and 4.4 mg/kg, respectively. The Cmax was increased approximately twofold following multiple doses of 2.2 mg/kg (Cmax = 13.1 micrograms/mL) and 4.4 mg/kg (Cmax = 24.1 micrograms/mL). Ceftiofur accumulated slowly into TCF and peak concentrations were found to be approximately 14% of those observed in serum after the first dose and approximately 24% after multiple dosing. Concentrations of ceftiofur in BS were obtained rapidly with peak concentrations reaching 45% of the serum Cmax after the first dose. After multiple dosing the Cmax for BS was approximately 25% of the serum Cmax. This study found that both the 2.2 mg/kg and 4.4 mg/kg dosing regimens resulted in continuous serum, TCF and BS concentrations of ceftiofur that exceeded the minimal concentration required to inhibit the bacteria most frequently isolated from calves with acute bovine respiratory disease.